Clinical utility of denosumab for treatment of bone loss in men and women
Open Access
- 1 May 2011
- journal article
- review article
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. 6, 119-24
- https://doi.org/10.2147/CIA.S14565
Abstract
Peer reviewed article authored by (Adler R, Gill RS). Read article or submit your manuscript for publishing.Keywords
This publication has 43 references indexed in Scilit:
- Bisphosphonates for post-menopausal osteoporosis: are they all the same?QJM: An International Journal of Medicine, 2011
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyJournal of Clinical Oncology, 2010
- Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group ReportOsteoporosis International, 2010
- Exposure to Oral Bisphosphonates and Risk of Esophageal CancerJAMA, 2010
- Oral bisphosphonate compliance and persistence: a matter of choice?Osteoporosis International, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate CancerNew England Journal of Medicine, 2009
- Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate CancerJAMA, 2008
- Androgen deprivation therapy for prostate cancer: new concepts and concernsCurrent Opinion in Endocrinology, Diabetes and Obesity, 2007
- Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025Journal of Bone and Mineral Research, 2007